Research programme: biosimilars - BionovisAlternative Names: BNV-003; BNV-004
Latest Information Update: 09 Jun 2015
At a glance
- Originator Bionovis
- Mechanism of Action Epidermal growth factor receptor antagonists; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Colorectal cancer; Head and neck cancer; Multiple sclerosis
Most Recent Events
- 09 Jun 2015 Preclinical trials in Colorectal cancer in Brazil (unspecified route) before June 2015
- 09 Jun 2015 Preclinical trials in Multiple sclerosis in Brazil (unspecified route) before June 2015
- 09 Jun 2015 Preclinical trials in Head and neck cancer in Brazil (unspecified route) before June 2015